Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07011173 · ClinicalTrials.gov registry record · Early Phase 1
Assistance Delivery and Muscle Coordination
A Early Phase 1 study of Stroke, sponsored by The Catholic University of America.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07011173: Recruiting Early Phase 1 study of Stroke, sponsored by The Catholic University of America.
NCT07011173 is a Early Phase 1 study of Stroke that is actively recruiting participants, run by The Catholic University of America. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07011173, a Early Phase 1 study of Stroke, is actively recruiting participants, sponsored by The Catholic University of America.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The experiment will be conducted with 15 chronic stroke survivors and 15 control subjects. Subjects will perform extension movements of the index finger of their more-impaired (stroke) or nondominant (control) hand under two different assistance types: end-effector assistance and exotendon assistance. For each assistance type, unassisted movements will be performed before and after the assistance. Subjects will be randomly assigned into two groups (A and B), who will receive the assistance in a different order. The finger movements and muscle activation patterns will be recorded during movements.
Primary Outcome
Coordination of different hand muscles
Conditions Studied
Interventions
- DEVICE Exotendon assistance
- DEVICE End-effector assistance
Study Locations (1)
District of Columbia
- Catholic University of America - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
What NCT07011173 shows while recruiting
NCT07011173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Exotendon assistance is the first listed.
NCT07011173 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07011173 about?
NCT07011173 is a clinical study titled "Assistance Delivery and Muscle Coordination". The experiment will be conducted with 15 chronic stroke survivors and 15 control subjects. Subjects will perform extension movements of the index finger of their more-impaired (stroke) or nondominant (control) hand under two different assistance types: end-effector assistance and exotendon assistanc...
What is the current status of trial NCT07011173?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2024-11-21. Estimated completion is 2025-12-31.
What conditions does trial NCT07011173 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT07011173?
The interventions under investigation include: Exotendon assistance (DEVICE), End-effector assistance (DEVICE).
Who is sponsoring clinical trial NCT07011173?
This trial is sponsored by The Catholic University of America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07011173 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07011173's enrollment target sits among peer trials
30 301st of 454 higher than 137 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Primed Stroke Rehabilitation
RECRUITING · Early Phase 1
-
R01.Aim 2.Study 1: IsoReach
RECRUITING · Early Phase 1
-
Effect of Neural Constraints on Movement in Stroke
RECRUITING · Early Phase 1
-
Multisensory Augmentation for Post-stroke Standing Balance
RECRUITING · Early Phase 1
-
Cognition and Motor Learning Post-stroke
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI